510(k) device
Embozene Color-Advanced Microspheres
Boston Scientific · Agents, Embolic, For Treatment Of Benign Prostatic Hyperplasia (NOY, Class II) · First FDA decision Apr 19, 2018, newest Apr 19, 2018Enlarged prostate (BPH)
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
5
Naming "Embozene Color-Advanced Microspheres"
MAUDE reports
0
Brand "Embozene Color-Advanced Microspheres", since 2015
PubMed studies
0
Mentioning "Embozene Color-Advanced Microspheres"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Embozene Color-Advanced Microspheres
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K180102 · Decided Apr 19, 2018 · 93 days after receipt
Device type: Agents, Embolic, For Treatment Of Benign Prostatic Hyperplasia (NOY) · GI, Urology & Nephrology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Fluid Jet System in the Treatment of Benign Prostatic Hyperplasia (BPH)Local determinationIn effectL38378CGS Administrators, LLCUpdated Mar 25, 2026
- Erythropoiesis Stimulating Agents (ESAs) for Treatment of Anemia in Adults with CKD Including Patients on Dialysis and Patients not on DialysisNational analysisReview closedCAG-00413NUpdated Sep 17, 2026
- PSA (Addition of ICD-9-CM 600.21, Benign localized hyperplasia of prostate with urinary obstruction as a covered indication)Coding analysisReview closedCAG-00332NUpdated Sep 15, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Embozene Color-Advanced Microspheres", any status and sponsor, newest update first.
University of Alabama at BirminghamAcademic, hospital or other
NCT07136571 · 0 participants · Start Feb 2026 · Primary completion Feb 2028
Device: bland particles · For: Soft Tissue Sarcomas
- Genicular Artery Embolization Vs Observation for Symptomatic Knee OsteoarthritisPivotal-lookingActive, not recruiting
University of California, Los AngelesAcademic, hospital or other
NCT04682652 · 100 participants (planned) · Start Aug 1, 2023 · Primary completion Oct 1, 2026
Device: Embozene MicroSpheres · For: Knee Osteoarthritis; Degenerative Joint Disease of Knee
Sites: Santa Monica, California
- Geniculate Artery Embolization for Treatment of Persistent Knee Pain Post Total Knee ArthroplastyTerminated
NYU Langone HealthAcademic, hospital or other
NCT06134817 · 2 participants · Start May 24, 2024 · Primary completion Feb 12, 2025
Device: Embozene Color-Advanced Microspheres. · For: Knee Pain
Sites: New York, New York
2 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Embozene Color-Advanced Microspheres", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code NOY
3 reports: 0 malfunction, 2 injury, 1 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Embozene Color-Advanced Microspheres"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code NOY.
- Bead Block (100 - 300µmBiocompatibles UK Ltd (Part of Boston Scientific Corporation · 510(k) 2021
- HydroPearl MicrospheresMicroVention, Inc. · 510(k) 2020
- Embosphere MicrospheresBiosphere Medical, S.A. · De Novo 2017
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.